CARISMA THERAPEUTICS Trademark

Trademark Overview

On Monday, September 14, 2020, a trademark application was filed for CARISMA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the CARISMA THERAPEUTICS trademark a serial number of 90179284. The federal status of this trademark filing is REGISTERED as of Tuesday, August 20, 2024. This trademark is owned by Carisma Therapeutics Inc.. The CARISMA THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations, namely, preparations for use in the treatment of cancer and tumors; biologic preparations for medical and therapeutic purposes for immunotherapy; biological preparations for immunotherapy, including, macrophage platforms and T Cell therapy; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use
carisma therapeutics

General Information

Serial Number90179284
Word MarkCARISMA THERAPEUTICS
Filing DateMonday, September 14, 2020
Status700 - REGISTERED
Status DateTuesday, August 20, 2024
Registration Number7482489
Registration DateTuesday, August 20, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 2, 2021

Trademark Statements

Description of MarkThe mark consists of the stylized word "CARISMA" in grey above the stylized word "THERAPEUTICS" in light blue, all appearing to the right of an image of a cell with receptors composed of a light blue circle surrounded by six light blue circles within the light blue outline of a circle interrupted by six, outward-facing, and light blue semicircles, each of which contains an orange circle. The color white represents background and is not claimed as a feature of the mark.
Goods and ServicesBiological preparations, namely, preparations for use in the treatment of cancer and tumors; biologic preparations for medical and therapeutic purposes for immunotherapy; biological preparations for immunotherapy, including, macrophage platforms and T Cell therapy; cells for medical or clinical use; diagnostic kits consisting primarily of cells for medical or clinical use
Pseudo MarkCHARISMA THERAPEUTICS
Indication of Colors claimedThe colors grey, blue, and orange are claimed as a feature of the mark.
Translation of Words in MarkThe English translation of the word "CARISMA" in the mark is "CHARISMA"
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 22, 2020
Primary Code005
First Use Anywhere DateTuesday, January 3, 2023
First Use In Commerce DateTuesday, January 3, 2023

Trademark Owner History

Party NameCarisma Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19014
Party NameCarisma Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19014
Party NameCarisma Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19014

Trademark Events

Event DateEvent Description
Thursday, September 17, 2020NEW APPLICATION ENTERED
Tuesday, January 26, 2021ASSIGNED TO EXAMINER
Thursday, October 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 23, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, January 27, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 27, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 27, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, January 27, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, January 27, 2021EXAMINER'S AMENDMENT ENTERED
Friday, August 27, 2021SOU EXTENSION 1 FILED
Wednesday, February 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, March 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 27, 2021SOU TEAS EXTENSION RECEIVED
Monday, March 28, 2022SOU TEAS EXTENSION RECEIVED
Friday, August 27, 2021SOU EXTENSION 1 GRANTED
Tuesday, August 31, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 28, 2022SOU EXTENSION 2 FILED
Monday, March 28, 2022SOU EXTENSION 2 GRANTED
Monday, March 27, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, March 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 28, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, September 28, 2022SOU EXTENSION 3 FILED
Wednesday, September 28, 2022SOU EXTENSION 3 GRANTED
Friday, September 30, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 27, 2023SOU EXTENSION 4 FILED
Monday, March 27, 2023SOU EXTENSION 4 GRANTED
Thursday, October 26, 2023SOU EXTENSION 5 GRANTED
Thursday, October 5, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 5, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 5, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 5, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 5, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 11, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, October 11, 2023SOU EXTENSION 5 FILED
Monday, October 23, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 23, 2024USE AMENDMENT FILED
Wednesday, January 24, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 23, 2024TEAS STATEMENT OF USE RECEIVED
Friday, June 21, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, June 21, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 2, 2024SU - NON-FINAL ACTION - WRITTEN
Friday, February 2, 2024NON-FINAL ACTION E-MAILED
Friday, February 2, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 27, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 21, 2024ASSIGNED TO LIE
Sunday, July 14, 2024SU - NON-FINAL ACTION - WRITTEN
Sunday, July 14, 2024NON-FINAL ACTION E-MAILED
Sunday, July 14, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 16, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 16, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 20, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, August 20, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

therapeutics carisma preparations medical biological clinical cells immunotherapy namely treatment therapy diagnostic